Cargando…

Harmine, a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor induces caspase-mediated apoptosis in neuroblastoma

BACKGROUND: Neuroblastoma (NB) is an early childhood malignancy that arises from the developing sympathetic nervous system. Harmine is a tricyclic β-carboline alkaloid isolated from the harmal plant that exhibits both cytostatic and cytotoxic effects. Harmine is capable of blocking the activities of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uhl, Katie L., Schultz, Chad R., Geerts, Dirk, Bachmann, André S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992763/ https://www.ncbi.nlm.nih.gov/pubmed/29977157 http://dx.doi.org/10.1186/s12935-018-0574-3

Ejemplares similares

Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
por: Lindberg, Mattias F., et al.
Publicado: (2021)

Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases
por: Correa-Sáez, Alejandro, et al.
Publicado: (2020)

β-Carboline Compounds, Including Harmine, Inhibit DYRK1A and Tau Phosphorylation at Multiple Alzheimer's Disease-Related Sites
por: Frost, Danielle, et al.
Publicado: (2011)

Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer
por: Yan, Haiyan, et al.
Publicado: (2016)

DYRK1A (Dual-Specificity Tyrosine-Phosphorylated and -Regulated Kinase 1A): A Gene with Dosage Effect During Development and Neurogenesis
por: Dierssen, M., et al.
Publicado: (2006)

A pan-cancer analysis of the oncogenic role of dual-specificity tyrosine (Y)-phosphorylation- regulated kinase 2 (DYRK2) in human tumors
por: Qiu, Xinyue, et al.
Publicado: (2022)

Harmine suppresses hyper-activated Ras–MAPK pathway by selectively targeting oncogenic mutated Ras/Raf in Caenorhabditis elegans
por: Ji, Jiaojiao, et al.
Publicado: (2019)

Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy: DYRK2 is associated with survival in bladder cancer
por: Nomura, Shunichiro, et al.
Publicado: (2015)

Role of dual specificity tyrosine-phosphorylation-regulated kinase 1B (Dyrk1B) in S-phase entry of HPV E7 expressing cells from quiescence
por: Zhou, Na, et al.
Publicado: (2015)

Polyamine Biosynthetic Pathway as a Drug Target for Osteosarcoma Therapy
por: Weicht, Rebecca R., et al.
Publicado: (2018)

How to Separate Kinase Inhibition from Undesired Monoamine Oxidase A Inhibition—The Development of the DYRK1A Inhibitor AnnH75 from the Alkaloid Harmine
por: Wurzlbauer, Anne, et al.
Publicado: (2020)

Combination CDC-like kinase inhibition (CLK)/Dual-specificity tyrosine-regulated kinase (DYRK) and taxane therapy in CTNNB1-mutated endometrial cancer
por: Corr, Bradley R, et al.
Publicado: (2023)

Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors
por: Aveic, Sanja, et al.
Publicado: (2018)

Pharmacophore and 3D-QSAR Characterization of 6-Arylquinazolin-4-amines as Cdc2-like Kinase 4 (Clk4) and Dual Specificity Tyrosine-phosphorylation-regulated Kinase 1A (Dyrk1A) Inhibitors
por: Pan, Yongmei, et al.
Publicado: (2013)

Proliferation of Ewing sarcoma cell lines is suppressed by the receptor tyrosine kinase inhibitors gefitinib and vandetanib
por: Andersson, Mattias K, et al.
Publicado: (2008)

Impaired Spatial Learning Strategies and Novel Object Recognition in Mice Haploinsufficient for the Dual Specificity Tyrosine-Regulated Kinase-1A (Dyrk1A)
por: Arqué, Glòria, et al.
Publicado: (2008)

Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A
por: Widowati, Esti Wahyu, et al.
Publicado: (2018)

Multi-tyrosine kinase inhibitors in preclinical studies for pediatric CNS AT/RT: Evidence for synergy with Topoisomerase-I inhibition
por: Jayanthan, Aarthi, et al.
Publicado: (2011)

Liver X receptor activation induces apoptosis of melanoma cell through caspase pathway
por: Zhang, Wenjun, et al.
Publicado: (2014)

Mirk/Dyrk1B mediates G0/G1 to S phase cell cycle progression and cell survival involving MAPK/ERK signaling in human cancer cells
por: Gao, Jingchun, et al.
Publicado: (2013)

Dual Specificity Kinase DYRK3 Promotes Aggressiveness of Glioblastoma by Altering Mitochondrial Morphology and Function
por: Kim, Kyeongmin, et al.
Publicado: (2021)

Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
por: Papenfuss, Marco, et al.
Publicado: (2022)

Data supporting a pilot high-throughput screen of a drug library for identification of DYRK1A inhibitors and high-content imaging analysis of identified harmine analogs
por: Tarpley, Michael, et al.
Publicado: (2021)

Variant RONΔ160 of the RON receptor tyrosine kinase promotes the growth and invasion in vitro and in vivo in gastric cancer cell lines
por: Zhou, Dong-Hui, et al.
Publicado: (2015)

The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells
por: Silveira, Elaine, et al.
Publicado: (2018)

New K50R mutant mouse models reveal impaired hypusination of eif5a2 with alterations in cell metabolite landscape
por: Schultz, Chad R., et al.
Publicado: (2023)

Caspase Cleavage of Receptor Tyrosine Kinases in the Dependence Receptor Family
por: Park, Gyu Hwan, et al.
Publicado: (2023)

Caspase-8 and Tyrosine Kinases: A Dangerous Liaison in Cancer
por: Contadini, Claudia, et al.
Publicado: (2023)

Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology
por: Rozen, Esteban Javier, et al.
Publicado: (2021)

Mirk/dyrk1B Kinase in Ovarian Cancer
por: Friedman, Eileen
Publicado: (2013)

Roles of dual specificity tyrosine-phosphorylation-regulated kinase 2 in nervous system development and disease
por: Santos-Durán, Gabriel Nicolás, et al.
Publicado: (2022)

Hypericin-mediated photodynamic therapy induces apoptosis of myoloma SP2/0 cells depended on caspase activity in vitro
por: Zhang, Junping, et al.
Publicado: (2014)

TRIM36 inhibits tumorigenesis through the Wnt/β-catenin pathway and promotes caspase-dependent apoptosis in hepatocellular carcinoma
por: Tong, Qing, et al.
Publicado: (2022)

The DYRK-family kinase Pom1 phosphorylates the F-BAR protein Cdc15 to prevent division at cell poles
por: Ullal, Pranav, et al.
Publicado: (2015)

Retraction: The DYRK-family kinase Pom1 phosphorylates the F-BAR Cdc15 to prevent division at cell poles
por: Ullal, Pranav, et al.
Publicado: (2017)

Regulatory Phosphorylation of Ikaros by Bruton's Tyrosine Kinase
por: Ma, Hong, et al.
Publicado: (2013)

A 6-gene signature identifies four molecular subgroups of neuroblastoma
por: Abel, Frida, et al.
Publicado: (2011)

Inhibition of CDK4/6 as a novel therapeutic option for neuroblastoma
por: Rihani, Ali, et al.
Publicado: (2015)

Inhibitor of caspase-activated DNase expression enhances caspase-activated DNase expression and inhibits oxidative stress-induced chromosome breaks at the mixed lineage leukaemia gene in nasopharyngeal carcinoma cells
por: Boon, Siaw Shi, et al.
Publicado: (2015)

Dyrk1a Phosphorylation of α-Synuclein Mediating Apoptosis of Dopaminergic Neurons in Parkinson's Disease
por: Yong, Yuxuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1dnjtrh42e0t3dj653b08thdk4